While reduced edema associated with NKCC1 inhibition by bumetanide may lessen stroke injury (O'Donnell et al., 2004), the blunting of [Ca2+]i overload in response to ischemia-acidosis by BMN would also improve outcomes in stroke. Here, SLC12A2 is linked to Stroke.